Physician profile
Xiaodong Yang
NPI 1114069713
$19,627.37
in general payments reported to CMS, 2019-2025
8 companies · $19K in 2025
The $19K reported for 2025 was more than what 98% of Critical Care Medicine (Anesthesiology) providers received nationally (typical 2025 total: $97.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.08 · 2023: $148 · 2024: $750 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $15K · Travel and Lodging: $3,644 · Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $15,084.00 |
| Travel and Lodging | $3,643.75 |
| Food and Beverage | $853.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15,084.00 | 2025 | |
| Abbott Laboratories | $3,000.95 | 2024-2025 | Triclip, Mitraclip |
| Abiomed | $783.39 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $498.01 | 2025 | Evoque, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $171.65 | 2023-2025 | Watchman Flx |
| Mallinckrodt Enterprises LLC | $46.08 | 2019 | |
| Philips North America LLC | $25.92 | 2025 | Ice 3d |
| Haemonetics Corporation | $17.37 | 2025 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaodong Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.